From the category archives:

MedWatch

Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall – Mislabeled Overpouch

November 21, 2014

Administration of a dose lower than intended, especially in patients prone to severe electrolyte imbalance, may lead to serious, life-threatening adverse health consequences. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details [...]

Read More Details →

Forever Beautiful Bee Pollen by REFA Enterprises: Recall – Undeclared Drug Ingredients

November 20, 2014

Risk for those with a history of coronary artery disease, congestive heart failure, arrhymias or stroke This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall – Power Failure May Occur

November 19, 2014

Failure of power supply may cause ventilator to shut off, resulting in too much carbon dioxide or not enough oxygen in patient’s blood, or death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View [...]

Read More Details →

ABC Dophilus Powder by Solgar, Inc: Recall – Risk of Infection

November 17, 2014

The product was found to contain Rhizopus oryzae, which may cause health problems to consumers, particularly premature infants/infants, children, and those with weakened immune systems. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View [...]

Read More Details →

Long-term Antiplatelet Therapy: Safety Announcement – Preliminary Trial Data Shows Benefits But a Higher Risk of Non-Cardiovascular Death

November 16, 2014

FDA believes the benefits of clopidogrel (Plavix) and prasugrel (Effient) therapy continue to outweigh their potential risks when used for approved uses. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of [...]

Read More Details →

Gel-E Donut and Squishon 2 Products by Children’s Medical Ventures: Recall – Potential Mold Contamination

November 14, 2014

There is the possibility of fungal infection should patients come in contact with the mold. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Mayhem: Public Notification – Undeclared Drug Ingredients

November 14, 2014

Risk of impaired ability to fight infections, high blood sugar levels, muscle injuries, and psychiatric problems. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall – Software Issue May Stop Ventilator

November 7, 2014

Ventilator may stop working after the air and oxygen gas supply lines are disconnected and then reconnected. This can lead to serious health problems or death. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. [...]

Read More Details →

GemStar Power Supply, 3VDC for GemStar Infusion Pumps by Hospira: Class I Recall – Power Supply May Not Deliver Enough Electricity

November 5, 2014

Use of recalled devices may cause serious health risks, including delay in therapy, delivery of too much fluid, too high or too low blood pressure, slow or fast heart rhythm/beat, shock, trauma, 1st or 2nd degree burns, smoke inhalation, problems breathing, stroke, and death. This is a summary of an alert issued by MedWatch: The [...]

Read More Details →

V26 Slimming Coffee: Public Notification – Undeclared Drug Ingredient

November 5, 2014

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The [...]

Read More Details →